Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | BMC Cancer

Fig. 4

From: Demethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway

Fig. 4

Representative immunohistochemical staining of HIN-1 in OCCC cancerous tissues. a Weak expression of HIN-1. b High expression of HIN-1. Note: The high HIN-1 expression was noted in the cytoplasm of the neoplastic cells (arrows). c Bar figures of the percentage of weak and strong HIN-1 protein expression in paclitaxel-resistant and paclitaxel-sensitive OCCC tissues

Back to article page